Details for New Drug Application (NDA): 019129
✉ Email this page to a colleague
The generic ingredient in MAXZIDE-25 is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 019129
Tradename: | MAXZIDE-25 |
Applicant: | Aurobindo Pharma Usa |
Ingredient: | hydrochlorothiazide; triamterene |
Patents: | 0 |
Pharmacology for NDA: 019129
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Suppliers and Packaging for NDA: 019129
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129 | NDA | Mylan Pharmaceuticals Inc. | 0378-0460 | 0378-0460-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0460-01) |
MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129 | NDA | Mylan Pharmaceuticals Inc. | 0378-0460 | 0378-0460-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0460-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG;75MG | ||||
Approval Date: | Oct 22, 1984 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;37.5MG | ||||
Approval Date: | May 13, 1988 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 019129
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription